Table 1.
Number of quantitative indicators retrieved, grouped in categories according to the cancer care pathway (n = 1013)
| Number of indicators with quantitative information a) | Number of studies | ||
|---|---|---|---|
| n | % | ||
| Early detection | 59 | 6% | |
| Number of screening procedures | 33 | 13 | |
| Early diagnosis and predisposition exams | 12 | 7 | |
| Screening detection rates | 14 | 5 | |
| Diagnosis and staging | 418 | 41% | |
| Delay in access to diagnostic procedures | 9 | 2 | |
| Clinical severity at diagnosis | 14 | 7 | |
| Changes in cancer staging | 110 | 21 | |
| Proportion of urgent/emergent referrals and procedures | 25 | 5 | |
| Number of diagnostic, surveillance, and staging exams/procedures | 90 | 17 | |
| Number of cancer diagnoses | 157 | 40 | |
| Cancer detection rate | 13 | 5 | |
| Treatment | 497 | 49% | |
| Delay in treatment | 42 | 18 | |
| Number of treatments | |||
| •Surgeries & loco-regional therapies | 104 | 30 | |
| • Radiotherapy | 57 | 8 | |
| • Systemic therapy | 71 | 12 | |
| Number of referrals / first encounters | 41 | 9 | |
| Outpatient volume | 47 | 14 | |
| Changes in treatment | 119 | 21 | |
| Number of visits and hospital admissions | 12 | 4 | |
| Telemedicine utilization | 4 | 4 | |
| Outcomes | 39 | 4% | |
| Surgical and procedures outcome measures | 15 | 8 | |
| Mortality | 24 | 4 | |
| 1013 | 100% | ||
a)A total of 338 indicators were not included in the analysis since they were too specific to be grouped into the defined categories